2/9
04:16 pm
enta
Enanta Pharmaceuticals: Fiscal Q1 Earnings Snapshot [Yahoo! Finance]
Neutral
Report
Enanta Pharmaceuticals: Fiscal Q1 Earnings Snapshot [Yahoo! Finance]
2/9
04:01 pm
enta
Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2025
Medium
Report
Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2025
1/9
08:02 am
enta
Enanta Pharmaceuticals (NASDAQ:ENTA) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
Low
Report
Enanta Pharmaceuticals (NASDAQ:ENTA) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
1/8
07:27 am
enta
Enanta Pharmaceuticals Provides Update on its Research and Development Programs and 2026 Outlook [Yahoo! Finance]
Low
Report
Enanta Pharmaceuticals Provides Update on its Research and Development Programs and 2026 Outlook [Yahoo! Finance]
1/8
07:00 am
enta
Enanta Pharmaceuticals Provides Update on its Research and Development Programs and 2026 Outlook
Low
Report
Enanta Pharmaceuticals Provides Update on its Research and Development Programs and 2026 Outlook
1/5
07:13 am
enta
Enanta Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Medium
Report
Enanta Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
1/5
07:00 am
enta
Enanta Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
Medium
Report
Enanta Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
1/1
08:35 am
enta
Enanta Pharmaceuticals Insider Ups Holding During Year [Yahoo! Finance]
Medium
Report
Enanta Pharmaceuticals Insider Ups Holding During Year [Yahoo! Finance]
11/19
03:03 pm
enta
Enanta: Maintaining Buy Rating Based On Zelicapavir Potential In RSV Development [Seeking Alpha]
Low
Report
Enanta: Maintaining Buy Rating Based On Zelicapavir Potential In RSV Development [Seeking Alpha]
11/17
04:45 pm
enta
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year-Ended September 30, 2025 [Yahoo! Finance]
Low
Report
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year-Ended September 30, 2025 [Yahoo! Finance]
11/17
04:12 pm
enta
Enanta Pharma GAAP EPS of -$0.87, revenue of $15.1M [Seeking Alpha]
Medium
Report
Enanta Pharma GAAP EPS of -$0.87, revenue of $15.1M [Seeking Alpha]
11/17
04:01 pm
enta
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year-Ended September 30, 2025
Low
Report
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year-Ended September 30, 2025
11/14
08:09 am
enta
Enanta Pharmaceuticals (NASDAQ:ENTA) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $17.00 price target on the stock.
Low
Report
Enanta Pharmaceuticals (NASDAQ:ENTA) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $17.00 price target on the stock.